Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Conditions: Alzheimer Disease; Dementia Alzheimers; Dementia; Cognitive Impairment; Mild Cognitive Impairment; Neurodegenerative Diseases; Neurocognitive Disorders; Neurocognitive Dysfunction; Cognitive Dysfunction; Mental Disorder Intervention: Device: Emerald Device Monitoring Sponsors: Mclean Hospital; National Institute on Aging (NIA) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alzheimer's | Brain | Dementia | Hospitals | Information Technology | Men | Neurology | Research | Vitamin B3